QT
BIO icon

Quantamental Technologies’s Bio-Rad Laboratories Class A BIO Stock Holding History

Quantamental Technologies’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$248K – 506
2022
Q2 		$248K Sell
500
-1,124
-69% -$585K 0.11% 303
2022
Q1 		$915K Buy
+1,624
New +$979K 0.53% 38
2020
Q3 		– Sell
-1,971
Closed -$890K – 264
2020
Q2 		$890K Buy
+1,971
New +$870K 0.59% 52
2020
Q1 		– Sell
-2,060
Closed -$762K – 144
2019
Q4 		$762K Buy
+2,060
New +$726K 0.39% 62
2019
Q2 		– Sell
-1,005
Closed -$307K – 1476
2019
Q1 		$307K Sell
1,005
-1,500
-60% -$405K 0.14% 232
2018
Q4 		$582K Buy
+2,505
New +$672K 0.35% 26

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return